News

FMC Corporation Announces Impressive Q3 Performance and Updates

FMC Corporation Announces Impressive Q3 Performance and Updates

FMC Corporation Reports Strong Revenue Growth in Q3

FMC Corporation has announced remarkable growth in revenue during the third quarter of 2024, driven by increased sales volume and cost efficiency. This growth has positioned the company favorably as it navigates through challenging market conditions.

Key Highlights from Third Quarter 2024

Third Quarter Performance Metrics:

  • Revenue reached $1.07 billion, marking a 9 percent increase compared to Q3 2023 and a 12 percent upsurge on an organic basis.
  • FMC achieved a consolidated GAAP net income of $66 million, a remarkable recovery from a loss of $4 million in Q3 2023.
  • The adjusted EBITDA was reported at $201 million, reflecting a 15 percent rise year-over-year.
  • Net income per diluted share was $0.52 compared to a net loss of $0.03 in the prior year.
  • Adjusted earnings per diluted share surged 57 percent to $0.69.
  • Cash from operations was $160 million, with free cash flow totaling $132 million.

Outlook for the Full Year 2024

This quarter's performance leads FMC to reaffirm its guidance for the full year 2024 while making adjustments to account for the anticipated sale of its Global Specialty Solutions (GSS) business:

  • Revenue outlook is between $4.33 billion and $4.44 billion, demonstrating a conservative decline at the midpoint compared to the previous year.
  • Adjusted EBITDA is expected to range from $885 million to $915 million.
  • Adjusted earnings per diluted share are projected between $3.16 and $3.52, implying a decrease versus 2023's figures.
  • The company also increased its target restructuring savings, with an expected benefit of $125 million to $150 million.
  • Free cash flow guidance remains stable at $400 million to $500 million.

Market Strength Amid Challenges

FMC's quarter-on-quarter growth is attributed to robust volume increases, especially noticeable in North America and Latin America. Despite lower pricing pressures from specific regions, the sales volume more than compensated, allowing FMC to maintain its market share effectively.

"We delivered revenue and earnings growth as market conditions improved, though at varying rates across the regions," expressed Pierre Brondeau, the chairman and CEO of FMC Corporation. He noted that while pricing in markets like Brazil and Argentina faced some challenges, the demand for innovative products remained strong, particularly those based on fluindapyr.">

Expectations for Subsequent Quarters

Heading into the fourth quarter, FMC anticipates further growth despite some orders being shifted from the latter part of the year to the third quarter. The optimism surrounding further earnings growth is underpinned by robust sales of new products and additional cost efficiencies resulting from the ongoing restructuring.

The adjusted EBITDA forecast for the upcoming quarter ranges from $321 million to $351 million, signaling a 32 percent increase compared to the same quarter last year. Likewise, adjusted earnings per diluted share for Q4 are expected to be between $1.47 and $1.83, reflecting a significant midpoint improvement of 54 percent.

Frequently Asked Questions

What was the revenue growth percentage for FMC in Q3 2024?

The revenue growth for FMC in Q3 2024 was 9 percent compared to Q3 2023.

How much cash flow from operations did FMC report for Q3 2024?

FMC reported cash from operations of $160 million for Q3 2024.

What is FMC's full-year earnings per share outlook for 2024?

FMC's full-year adjusted earnings per diluted share outlook ranges between $3.16 and $3.52.

Which regions contributed to FMC's volume growth?

FMC experienced strong volume growth primarily in North America and Latin America.

What is the adjusted EBITDA forecast for the fourth quarter of 2024?

The adjusted EBITDA forecast for Q4 2024 is between $321 million and $351 million, reflecting a significant increase.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Peptide Therapy Rules Change: Gameday Ups the Ante

Updated Category News Views 110

Gameday Men's Health: Leading the Safe Peptide Charge Finally, we got some regulatory sanity stepping up to the plate with peptides. You see, the FDA's new interim policy is letting state-licensed compounding pharmacies work their magic with peptides, but only under strict medical watch. And Gameday Men's Health sure ain't wasting any time setting up shop in this fresh...

Continue Reading
Fidelis Care Opens $120K Workforce Grants for Aid

Updated Category News Views 112

Fidelis Care Steps Up Workforce Engagement Fidelis Care's latest move introduces a fresh shot at tackling two birds with one stone—economic and health stability for Medicaid members. The Workforce Pathways to Health and Economic Mobility grants present up to $120,000 in support for New Yorkers, an attempt aimed squarely at reducing the vicious cycle that traps many in...

Continue Reading
Chip Earnings Fuel Market Gains Amid Volatility Dip

Updated Category News Views 56

Tech Earnings Drive Market Resilience Amid a climate of economic uncertainty, it's refreshing to see semiconductor and tech earnings offering a little backbone to the market. This week, the S&P 500 climbed 1.51%, while the Nasdaq Composite jumped 1.98% over three sessions. It's like watching Rocky get up off the mat—those indices pushing higher when it seemed like they...

Continue Reading
Read/Write Labs Tackles Brain-Tech Fusion Ambitions

Updated Category News Views 88

Buck up, investors! There's a new player on the field marrying AI and neuroscience with some serious firepower and a respectable roster. Read/Write Labs—what you might've known yesterday as Dandelion Science—has kicked off under a fresh banner, amping up efforts to decode and recode our noggin's electrical orchestra. And with the likes of Jim DiCarlo, Dan Yamins, and...

Continue Reading
Fannie Mae Q3 2026 Earnings Surpass Expectations

Updated Category News Views 84

An Upward Trend in Fannie Mae's Financials Hold onto your hats—Fannie Mae's swinging into action with hefty third-quarter numbers that'd make most firms drool. The latest figures, disclosed in their 10-Q filing, boast a net income of $4.2 billion for Q3 2026. You heard me right, billion! Now, to a market vet, these aren't digits to scoff at. And as the economy keeps...

Continue Reading
Aktia Bank: Steady Ratings, Focused Expansion in Europe

Updated Category News Views 123

Aktia's Ratings Get a Boost In the world of financial minutiae, it was S&P Global Ratings that took the stage, buzzing about Aktia Bank Plc. The bank just had its ratings held steady with an outlook lift from negative to stable. That's like someone throwing you a life jacket when you're treading water; significant if you're trying to stay afloat, not so much if you've got...

Continue Reading
ESENTIA Lifts EBITDA, Reduces Debt, Eyes Expansion

Updated Category News Views 38

ESENTIA Flexes Financial Muscles: What's the Deal? Walk with me through the gritty world of financials, and you’ll see that ESENTIA’s latest figures are a mixed bag with a tantalizing upside. We're talking about adjusted EBITDA ticking up to a cool $86 million in the third quarter of '26, a 1.3% lift from last year. Not too shabby, eh? Especially when you're grappling...

Continue Reading
VeriSilicon's GLTiny: Game-Changer for Wearable Tech

Updated Category News Views 45

Revolutionizing Wearable Graphics with GLTiny There's a fresh breeze blowing through the world of wearable tech, and VeriSilicon's GLTiny seems to be at the heart of it. When the silicon giant out of Shanghai tossed GLTiny into the mix, it wasn't just throwing another chip on the barbie. Oh no, this is a real pivot towards juicing up those smart gadgets strapped to your...

Continue Reading
Ballard’s HPU Agile-H Poised to Transform Portable Energy

Updated Category News Views 76

Another Step Forward with Hydrogen Ballard's got another ace up its sleeve with the HPU Agile-H. Now here’s the kicker—everyone’s scrambling for cleaner, more portable energy solutions, and Ballard’s stepped up. Born from their acquisition of GeoPura, this lightweight hydrogen powerhouse is engineered for those spots rudely ignored by the grid. Place your bets on...

Continue Reading
Replay Sports Cards Nets STAR Award for Innovation

Updated Category News Views 82

A New Era for Franchise Onboarding Just when you think the sports card world couldn't get any more niche, along comes Replay Sports Cards thumping its chest with some serious innovation. This Charlotte-based franchise just snagged the Franchise Innovation Award from Franchise Update Media. Yep, they're the only ones getting tips of the hat for the Most Innovative...

Continue Reading

Top 5 Most Recently Viewed Articles

Sollis Health Welcomes Katy Marshall as Chief Growth Officer

Updated Category News Views 511

Sollis Health Welcomes Katy Marshall as Chief Growth Officer The leading concierge medical provider has appointed Katy Marshall as Chief Growth Officer. With her extensive background in driving growth for consumer and healthcare brands, she will guide the company's marketing, sales, and product strategies. Experienced Leadership Katy brings a wealth of experience to...

Continue Reading
Kulicke & Soffa Delivers Strong Q4 Performance Highlights

Updated Category News Views 153

Strong Financial Performance in Q4 Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC) reported impressive financial results for the fourth quarter, showcasing resilience and growth in a challenging market. The company achieved a net revenue of $177.6 million, reflecting its ongoing commitment to innovation and operational efficiency. Lester Wong, the Interim Chief...

Continue Reading
Unlocking Dividend Income: Strategies for Salesforce Investors

Updated Category News Views 85

Understanding Salesforce's Dividend Potential Salesforce, Inc. (NYSE: CRM) is a leading company known for its innovative cloud-based solutions. With its upcoming fourth-quarter financial results, many investors are curious about how to maximize their returns, particularly through dividends. This approach can be an excellent way to create a significant income stream while...

Continue Reading
Investigation Launched into Sage Therapeutics' Recent Drug Trials

Updated Category News Views 93

Introducing Sage Therapeutics Sage Therapeutics, Inc. (NASDAQ: SAGE) is a biopharmaceutical company dedicated to developing innovative therapies aimed at enhancing brain health. However, recent events have raised serious concerns among investors, prompting an investigation into possible violations of federal securities laws. Stock Price Affected by Recent Events FDA...

Continue Reading
Genius Group Investors Can Pursue Class Action for Losses

Updated Category News Views 208

Genius Group Limited Faces Class Action Lawsuit Genius Group Limited, recognized by its ticker symbol GNUS, is currently embroiled in a class action lawsuit aimed at addressing significant investor losses. This legal action comes as a response to alleged stock market misconduct by certain trading firms. Investors Encouraged to Take Action The law firm Bronstein, Gewirtz &...

Continue Reading